These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 2107492)
1. 2-Aminopurine abolishes EGF- and TPA-stimulated pp33 phosphorylation and c-fos induction without affecting the activation of protein kinase C. Mahadevan LC; Wills AJ; Hirst EA; Rathjen PD; Heath JK Oncogene; 1990 Mar; 5(3):327-35. PubMed ID: 2107492 [TBL] [Abstract][Full Text] [Related]
2. 2-Aminopurine abolishes epidermal growth factor-stimulated phosphorylation of complexed and chromatin-associated forms of a 33 kDa phosphoprotein. Mahadevan LC; Targett K; Heath JK Oncogene; 1989 Jun; 4(6):699-706. PubMed ID: 2786618 [TBL] [Abstract][Full Text] [Related]
3. Intercellular heterogeneity of early mitogenic events: cAMP generalizes the EGF effect on c-Fos protein appearance but not on MAP kinase phosphorylation and nuclear translocation in dog thyroid epithelial cells. Baptist M; Dumont JE; Roger PP Exp Cell Res; 1995 Nov; 221(1):160-71. PubMed ID: 7589241 [TBL] [Abstract][Full Text] [Related]
4. Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells. Izumi H; Ono M; Ushiro S; Kohno K; Kung HF; Kuwano M Exp Cell Res; 1994 Oct; 214(2):654-62. PubMed ID: 7523156 [TBL] [Abstract][Full Text] [Related]
5. Quantitative dissociation between EGF effects on c-myc and c-fos gene expression, DNA synthesis, and epidermal growth factor receptor tyrosine kinase activity. Hauguel-DeMouzon S; Csermely P; Zoppini G; Kahn CR J Cell Physiol; 1992 Jan; 150(1):180-7. PubMed ID: 1730782 [TBL] [Abstract][Full Text] [Related]
6. [The c-fos proto-oncogene promotor is not regulated by serum, epidermal growth factor, and phorbol ester in embryonal fibroblasts transformed by E1Aad5+cHa-ras-oncogenes]. Pospelova TV; Medvedev AV; Kisliakova TV; Svetlikova SB; Pospelov VA Mol Biol (Mosk); 1991; 25(1):105-15. PubMed ID: 1716733 [TBL] [Abstract][Full Text] [Related]
7. Activation of signal transduction pathways protects quiescent Balb/c-3T3 fibroblasts against death due to serum deprivation. Tamm I; Kikuchi T J Cell Physiol; 1991 Jul; 148(1):85-95. PubMed ID: 1713593 [TBL] [Abstract][Full Text] [Related]
8. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation. Donato NJ; Ince C; Rosenblum MG; Gallick GE J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es). Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873 [TBL] [Abstract][Full Text] [Related]
10. Activation of the c-fos gene by UV and phorbol ester: different signal transduction pathways converge to the same enhancer element. Büscher M; Rahmsdorf HJ; Litfin M; Karin M; Herrlich P Oncogene; 1988 Sep; 3(3):301-11. PubMed ID: 2849742 [TBL] [Abstract][Full Text] [Related]
11. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation. Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346 [TBL] [Abstract][Full Text] [Related]
12. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Deng T; Karin M Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547 [TBL] [Abstract][Full Text] [Related]
13. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA. Li J; Ma C; Huang Y; Luo J; Huang C Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890 [TBL] [Abstract][Full Text] [Related]
14. Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos activation in androgen-sensitive prostate cancer cells. Day ML; Zhao X; Wu S; Swanson PE; Humphrey PA Cell Growth Differ; 1994 Jul; 5(7):735-41. PubMed ID: 7947388 [TBL] [Abstract][Full Text] [Related]
15. Activation of the c-fos enhancer by the erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites. Wang Y; Prywes R Oncogene; 2000 Mar; 19(11):1379-85. PubMed ID: 10723128 [TBL] [Abstract][Full Text] [Related]
16. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum. Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742 [TBL] [Abstract][Full Text] [Related]
17. Differential induction of c-fos and c-jun proto-oncogenes and AP-1 activity by tumor promoter 12-O-tetradecanoyl phorbol 13-acetate in cells at different stages of tumor promotion in vitro. Wu WS; Lin JK; Wu FY Oncogene; 1992 Nov; 7(11):2287-94. PubMed ID: 1437150 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter. Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800 [TBL] [Abstract][Full Text] [Related]
19. H-7, a protein kinase C inhibitor, inhibits phorbol ester-caused ornithine decarboxylase induction but fails to inhibit phorbol ester-caused suppression of epidermal growth factor binding in primary cultured mouse epidermal cells. Nakadate T; Yamamoto S; Aizu E; Nishikawa K; Kato R Mol Pharmacol; 1989 Dec; 36(6):917-24. PubMed ID: 2601687 [TBL] [Abstract][Full Text] [Related]
20. Successive occupancy by immediate early transcriptional factors of the tyrosine hydroxylase gene TRE and CRE sites in PACAP-stimulated PC12 pheochromocytoma cells. Yukimasa N; Isobe K; Nagai H; Takuwa Y; Nakai T Neuropeptides; 1999 Dec; 33(6):475-82. PubMed ID: 10657527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]